Prognosis

Botox Rivals Are Coming for AbbVie’s Crown Jewel

Cheaper alternatives threaten its $2.7 billion treatment.
A patient injected with a Botox treatment in Redondo Beach, CaliforniaPhotographer: Patrick T. Fallon/Bloomberg
Lock
This article is for subscribers only.

Hi! It’s Madison in New York, where I learned the Botox I’ve been injecting into my forehead for the past two years isn’t Botox at all. More on in a bit, but first ...

My story starts two years ago, after filming a short video for Bloomberg Originals. We’d just wrapped shooting and our cameraman, David, showed me the tape to review. While it may sound vain, my only thought was: “Oh god, I have forehead wrinkles.” While David assured me he could smooth the lines in postproduction, my mind was set: At the ripe age of 26, it was time to get Botox.